Changing the face of medicine from the Ground Up

Fluicell is transforming healthcare through innovative bioprinting and microfluidic research solutions, and tissue-based regenerative medicine, starting from the perspective of the individual cell.

Research solutions Regenerative Medicine

Dynaflow Resolve used in reserach showing potential new ways to treat pain

Chronic pain is a condition that affects approximately 20 percent of the adult population. Today, poor efficacy and…

Read more
31 Mar 2023

A new era for Dynaflow Resolve

We are excited to announce the relaunch of our high-precision ion channel screening platform Dynaflow® Resolve. With Dynaflow…

Read more
23 Mar 2023

Fluicell makes in vitro development progress in type 1 diabetes therapeutics program

Fluicell’s R&D team is demonstrating important progress in the Company’s type 1 diabetes therapeutics in vitro development and…

Read more
16 Mar 2023

What our customers say

“The BioPen System is one of the best single-cell treatment system on the market. It is easy-to-use, and gives me beautiful, publication-ready movies.”

Dr. Dani Cai from the National Institutes of Health

“The Dynaflow Resolve System is the most easy to use, and robust, perfusion system available for whole cell patch-clamp recordings of isolated cells. “

Prof. Kent Jadermark from Karolinska Institutet

“The BioPen system provide us with unique data with it you are able to see how cell process are trapped.”

Prof. Rizzo from the University of Maryland Medical Center

“After several years of use, we are satisfied with the Dynaflow Resolve system. It provides reliable and fast solution exchange.”

Gedeon Richter plc

“The BioPen system allows us to save money on expensive drugs because it uses very small amounts.”

U.S. Food and Drug Administration

“The Dynaflow Resolve system is a very reliable and efficient tool for automated compound application with excellent performance in fast solution exchange.

Dr. Timm Danker from NMI TT

“I chose the BioPen System because I can target precise areas of the cell. Consumption of expensive antibodies and drugs is minimized compared to perfusion of the whole cell as we used to have to do.”

Dr. Joseph Bruton from Karolinska Institutet

«The BioPen product is well designed and works even better than we could have hoped. The team is very reliable with customer support. I would highly recommend purchasing this product.»

Veronica Jove from the Rockefeller University

«For the application of expensive substances or small amounts of reagents, it’s challenging to use perfusion systems. Using the BioPen System allows us now to precisely perfuse only few single cells and record their subsequent reactions and metabolic changes.»

Roland Malli's Lab from Medical University of Graz